CFX

Colfax Corporation [CFX] Stock Forecast

Q: What is Colfax Corporation stock symbol ?

Colfax Corporation is a US stock, located in Annapolis junction of Maryland and trading under the symbol CFX

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

CFX Stock Summary

Earnings have grown 25.52% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

The Moving Average Convergence Divergence (MACD) for CFX recently turned positive (within last 10 days).

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

CFX has less than 1 year of cash runway

In the News

CFX Financial details

Company Rating

Buy

Market Cap

2.12B

Income

85.11M

Revenue

3.85B

Book val./share

179.4

Cash/share

27.95

Dividend

Dividend %

Employees

16.2K

Optionable

Shortable

Yes

Earnings

27 Apr 2022

P/E

92.09

Forward P/E

PEG

9.32

P/S

P/B

1.97

P/C

1.4

P/FCF

Quick Ratio

1.33

Current Ratio

2.25

Debt / Equity

0.49

LT Debt / Equity

0.48

EPS (TTM)

3.3

EPS next Y

EPS next Q

EPS this Y

130.72%

EPS next Y

EPS next 5Y

EPS last 5Y

-8.19%

Revenue last 5Y

3.15%

Revenue Q/Q

5.94%

EPS Q/Q

-55%

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

ROE

ROC

0.03%

Gross Margin

42%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

38.88-40.67

52W High

-2.35%

52W Low

+2.79%

RSI

Rel Volume

3.39

Avg Volume

871.93K

Volume

2.95M

Perf Week

Perf Month

Perf Quarter

Perf Half Y

Beta

2.12255

Volatility

13.74%, 13.74%

Prev Close

-41.46%

Price

39.06

Change

-41.67%

CFX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	128.22	142.47	129.28	119.31	149.75
Net income per share	5.87	5.45	-20.5	1.66	3.83
Operating cash flow per share	8.5	8.79	5.09	11.73	13.84
Free cash flow per share	5.83	6.09	0.22	7.27	9.79
Cash per share	15.99	9.52	4.26	3.77	27.95
Book value per share	136	127.04	133.71	137.67	179.4
Tangible book value per share	6.66	-4.37	-55.63	-54.01	-18.7
Share holders equity per share	136	127.04	133.71	137.67	179.4
Interest debt per share	42.82	48.29	96.02	97.69	91.2
Market cap	2.74B	2.74B	4.06B	4.16B	4.76B
Enterprise value	3.54B	3.7B	6.3B	6.47B	6.32B
P/E ratio	18.17	19.58	-7.7	97.54	48.28
Price to sales ratio	0.83	0.75	1.22	1.35	1.24
POCF ratio	12.55	12.13	31.01	13.77	13.38
PFCF ratio	18.3	17.51	732.14	22.22	18.92
P/B Ratio	0.78	0.84	1.18	1.17	1.03
PTB ratio	0.78	0.84	1.18	1.17	1.03
EV to sales	1.07	1.01	1.89	2.11	1.64
Enterprise value over EBITDA	9.66	11.34	-44.86	16.72	13.34
EV to operating cash flow	16.2	16.34	48.13	21.43	17.75
EV to free cash flow	23.62	23.6	1.14K	34.58	25.09
Earnings yield	0.06	0.05	-0.13	0.01	0.02
Free cash flow yield	0.05	0.06	0	0.05	0.05
Debt to equity	0.3	0.37	0.68	0.68	0.49
Debt to assets	0.16	0.18	0.32	0.33	0.27
Net debt to EBITDA	2.18	2.92	-15.96	5.98	3.28
Current ratio	1.89	1.63	1.64	1.68	2.25
Interest coverage	7.22	7.14	2.25	1.92	2.91
Income quality	1.45	1.61	-0.25	7.08	4.97
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.53	0.54	0.67	0.68	0.6
Capex to operating cash flow	-0.31	-0.31	-0.96	-0.38	-0.29
Capex to revenue	-0.02	-0.02	-0.04	-0.04	-0.03
Capex to depreciation	-0.52	-0.49	-0.53	-0.47	-0.4
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	134.03	124.78	248.34	71.62	124.41
ROIC	0.3	0.07	0.02	0.04	0.02
Return on tangible assets	0.05	0.05	-0.21	0.02	0.03
Graham Net	-63.27	-73.49	-119.68	-116.42	-88.09
Working capital	972.45M	759.1M	546.93M	550.17M	1.28B
Tangible asset value	171.52M	-112.58M	-1.43B	-1.39B	-481.32M
Net current asset value	-912.6M	-1.17B	-2.49B	-2.4B	-1.55B
Invested capital	0.3	0.37	0.68	0.68	0.49
Average receivables	941.91M	979.81M	775.64M	539.44M	577.85M
Average payables	596.51M	613.9M	500.22M	345.02M	417.21M
Average inventory	416.74M	463.08M	534.05M	568.19M	670.56M
Days sales outstanding	107.3	98.49	61.63	61.45	60.48
Days payables outstanding	94.38	92.28	68.17	67.62	82.13
Days of inventory on hand	69.06	71.52	108.29	115.65	126.46
Receivables turnover	3.4	3.71	5.92	5.94	6.03
Payables turnover	3.87	3.96	5.35	5.4	4.44
Inventory turnover	5.29	5.1	3.37	3.16	2.89
ROE	0.04	0.04	-0.15	0.01	0.02
Capex per share	-2.67	-2.71	-4.87	-4.46	-4.05

Quarterly Fundamentals Overview

Last date of statement is 2021-12-31 for Q1

Metric	2020-12-31	2021-03-31	2021-07-02	2021-10-01	2021-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	32.17	34.16	38.31	37.53	39.76
Net income per share	1.29	0.74	1.11	1	0.45
Operating cash flow per share	5	3.28	3.04	3.77	3.74
Free cash flow per share	3.71	2.33	2.26	2.65	2.55
Cash per share	3.77	29.67	2.42	6.9	27.95
Book value per share	137.67	164.99	167.37	178.2	179.4
Tangible book value per share	-54.01	-26.94	-28.19	-23.07	-18.7
Share holders equity per share	137.67	164.99	167.37	178.2	179.4
Interest debt per share	94.64	93.64	69.26	70.04	88.98
Market cap	4.16B	4.64B	4.92B	4.82B	4.76B
Enterprise value	6.47B	6.26B	6.62B	6.43B	6.32B
P/E ratio	31.3	60.78	42.9	46.63	103.2
Price to sales ratio	5.02	5.27	4.99	4.99	4.66
POCF ratio	32.28	54.95	62.72	49.63	49.52
PFCF ratio	43.49	77.48	84.36	70.71	72.66
P/B Ratio	1.17	1.09	1.14	1.05	1.03
PTB ratio	1.17	1.09	1.14	1.05	1.03
EV to sales	7.81	7.12	6.71	6.66	6.18
Enterprise value over EBITDA	56.15	54.21	54.9	49.23	58.94
EV to operating cash flow	50.24	74.16	84.44	66.22	65.69
EV to free cash flow	67.69	104.57	113.58	94.35	96.38
Earnings yield	0.01	0	0.01	0.01	0
Free cash flow yield	0.02	0.01	0.01	0.01	0.01
Debt to equity	0.68	0.56	0.41	0.39	0.49
Debt to assets	0.33	0.3	0.23	0.22	0.27
Net debt to EBITDA	20.07	14.04	14.12	12.34	14.5
Current ratio	1.68	1.33	1.64	1.77	2.25
Interest coverage	2.86	2.55	4.27	4.73	2.69
Income quality	3.88	4.42	2.74	3.76	-50.45
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.68	0.62	0.67	0.66	0.6
Capex to operating cash flow	-0.26	-0.29	-0.26	-0.3	-0.32
Capex to revenue	-0.04	-0.03	-0.02	-0.03	-0.03
Capex to depreciation	-0.51	-0.39	-0.3	-0.42	-0.47
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	63.22	52.45	64.74	63.46	42.55
ROIC	0.02	0.01	0.01	0.01	0
Return on tangible assets	0.01	0.01	0.01	0.01	0
Graham Net	-116.42	-89.11	-91.83	-90.19	-88.09
Working capital	550.17M	519.55M	579.55M	750.22M	1.28B
Tangible asset value	-1.39B	-693.42M	-725.49M	-593.79M	-481.32M
Net current asset value	-2.4B	-1.7B	-1.73B	-1.62B	-1.55B
Invested capital	0.68	0.56	0.41	0.39	0.49
Average receivables	507.68M	535.4M	576.83M	601.55M	620.96M
Average payables	318.28M	368.5M	430.23M	463.11M	488.34M
Average inventory	550.44M	585.52M	634.87M	722.26M	778.64M
Days sales outstanding	56.19	56.69	54.76	56.21	56.18
Days payables outstanding	62.78	72.04	72.03	75.8	75.06
Days of inventory on hand	107.37	107.37	105.33	125.29	115.57
Receivables turnover	1.6	1.59	1.64	1.6	1.6
Payables turnover	1.43	1.25	1.25	1.19	1.2
Inventory turnover	0.84	0.84	0.85	0.72	0.78
ROE	0.01	0	0.01	0.01	0
Capex per share	-1.29	-0.95	-0.78	-1.12	-1.19

CFX Frequently Asked Questions

What is Colfax Corporation stock symbol ?

Colfax Corporation is a US stock , located in Annapolis junction of Maryland and trading under the symbol CFX

What is Colfax Corporation stock quote today ?

Colfax Corporation stock price is $39.06 today.

Is Colfax Corporation stock public?

Yes, Colfax Corporation is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 871.93K
Market Capitalization 2.12B
Employee 16.2K
CEO Mr. Matthew Trerotola
Headquarters Annapolis Junction,MARYLAND,US
IPO Date 2008-05-08
Website https://www.colfaxcorp.com

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.